Approval · Notice of Compliance 21105 · 2018
TEPADINA: Notice of Compliance 21105
Issued July 19, 2018
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 21105
- Date
- July 19, 2018
- Company
- Adienne SaLugano, Tessin, Switzerland
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- ADDIOTIONAl DRUG PRODUCT MANUFACTURING SITE
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| TEPADINA | Not yet assigned | — |